FDA Inspection 1082694 — Tepnel Pharma Services Limited

Tepnel Pharma Services Limited — FEI 3006651658

The FDA completed an inspection of Tepnel Pharma Services Limited on March 11, 2019 in Glasgow. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 11, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Glasgow (United Kingdom)

Citations

IDCFRDescription
361121 CFR 211.160(b)(3)Acceptance of drug products
440221 CFR 211.192Written record of investigation incomplete
441821 CFR 211.42(b)Adequate space lacking to prevent mix-ups and contamination